Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa13
|
ENSMUSG00000038203.12 | homeobox A13 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_52260736_52261029 | Hoxa13 | 2 | 0.918966 | -0.15 | 2.9e-01 | Click! |
chr6_52261215_52261366 | Hoxa13 | 410 | 0.572702 | 0.06 | 6.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_131566380_131566679 | 12.78 |
Papss1 |
3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
1594 |
0.46 |
chr6_24863695_24863930 | 9.44 |
Hyal5 |
hyaluronoglucosaminidase 5 |
5815 |
0.19 |
chr11_26802655_26802967 | 8.90 |
Gm12070 |
predicted gene 12070 |
16178 |
0.2 |
chr6_61492448_61492759 | 8.50 |
Ccser1 |
coiled-coil serine rich 1 |
78067 |
0.11 |
chr3_79818299_79818691 | 8.46 |
Gm26420 |
predicted gene, 26420 |
16438 |
0.17 |
chr7_129937635_129938453 | 8.46 |
Gm4265 |
predicted gene 4265 |
24121 |
0.24 |
chr6_12260397_12260671 | 8.36 |
Thsd7a |
thrombospondin, type I, domain containing 7A |
57795 |
0.15 |
chr13_83742358_83742568 | 8.33 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3600 |
0.15 |
chr14_121564091_121564242 | 8.32 |
Dock9 |
dedicator of cytokinesis 9 |
20560 |
0.17 |
chr2_106716251_106716402 | 8.22 |
Mpped2 |
metallophosphoesterase domain containing 2 |
14164 |
0.23 |
chr1_118451170_118451325 | 7.76 |
Gm26080 |
predicted gene, 26080 |
2238 |
0.21 |
chr1_31233663_31234000 | 7.47 |
Pih1d3 |
PIH1 domain containing 3 |
10993 |
0.12 |
chr17_90892744_90892912 | 7.45 |
4930480K15Rik |
RIKEN cDNA 4930480K15 gene |
31659 |
0.22 |
chr7_61939801_61940302 | 7.24 |
Mir344-2 |
microRNA 344-2 |
55 |
0.95 |
chr4_111691023_111691585 | 7.12 |
Spata6 |
spermatogenesis associated 6 |
28680 |
0.21 |
chr12_35016864_35017229 | 7.08 |
Snx13 |
sorting nexin 13 |
30140 |
0.15 |
chr2_65930049_65930249 | 7.00 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
12 |
0.98 |
chr9_92856527_92856708 | 6.96 |
Gm28054 |
predicted gene 28054 |
39215 |
0.19 |
chr6_59171341_59171515 | 6.83 |
Gm43905 |
predicted gene, 43905 |
21825 |
0.19 |
chr1_114863120_114863308 | 6.66 |
Gm4854 |
predicted gene 4854 |
356549 |
0.01 |
chr14_103763810_103763977 | 6.63 |
Slain1os |
SLAIN motif family, member 1, opposite strand |
64451 |
0.11 |
chr13_83727942_83728228 | 6.53 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
21 |
0.96 |
chr1_144151888_144152189 | 6.52 |
Rgs13 |
regulator of G-protein signaling 13 |
25237 |
0.22 |
chr5_99084037_99084194 | 6.49 |
Prkg2 |
protein kinase, cGMP-dependent, type II |
46764 |
0.15 |
chrX_93300120_93300496 | 6.31 |
Arx |
aristaless related homeobox |
13798 |
0.23 |
chr15_58983859_58984038 | 6.25 |
4930544F09Rik |
RIKEN cDNA 4930544F09 gene |
188 |
0.94 |
chr13_78324889_78325040 | 6.19 |
Gm3963 |
predicted gene 3963 |
37880 |
0.11 |
chr18_88117590_88117977 | 6.17 |
Gm50391 |
predicted gene, 50391 |
21233 |
0.28 |
chr1_31364092_31364251 | 6.14 |
Gm6489 |
predicted gene 6489 |
77226 |
0.08 |
chr14_75219681_75219983 | 6.12 |
Gm15629 |
predicted gene 15629 |
20561 |
0.12 |
chr3_16816961_16817117 | 6.11 |
Gm26485 |
predicted gene, 26485 |
6273 |
0.34 |
chr14_99280961_99281121 | 6.00 |
Gm4412 |
predicted gene 4412 |
10595 |
0.18 |
chr4_39345356_39345507 | 5.99 |
Gm23607 |
predicted gene, 23607 |
49968 |
0.14 |
chr14_118230432_118230634 | 5.98 |
Gm4675 |
predicted gene 4675 |
5699 |
0.14 |
chr9_71879542_71879779 | 5.97 |
Tcf12 |
transcription factor 12 |
5051 |
0.13 |
chr2_10737244_10737438 | 5.96 |
Gm18547 |
predicted gene, 18547 |
156368 |
0.01 |
chr8_8568513_8568701 | 5.95 |
Gm31463 |
predicted gene, 31463 |
7915 |
0.15 |
chr16_8566072_8566398 | 5.95 |
Abat |
4-aminobutyrate aminotransferase |
6667 |
0.17 |
chr5_39153370_39153539 | 5.93 |
Gm42857 |
predicted gene 42857 |
150423 |
0.04 |
chr2_157347375_157347727 | 5.86 |
Ghrh |
growth hormone releasing hormone |
45 |
0.97 |
chr5_28689275_28689426 | 5.85 |
Gm43161 |
predicted gene 43161 |
112077 |
0.07 |
chr3_16938457_16938677 | 5.81 |
Gm26485 |
predicted gene, 26485 |
115255 |
0.07 |
chr2_6585129_6585315 | 5.80 |
Celf2 |
CUGBP, Elav-like family member 2 |
7578 |
0.27 |
chr4_141978530_141978821 | 5.73 |
Gm13059 |
predicted gene 13059 |
1896 |
0.24 |
chr10_37378360_37378791 | 5.70 |
Gm26535 |
predicted gene, 26535 |
41089 |
0.18 |
chr6_55444728_55444879 | 5.70 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
7175 |
0.21 |
chr1_70116336_70116487 | 5.69 |
Gm28580 |
predicted gene 28580 |
48356 |
0.18 |
chr14_12822580_12823213 | 5.68 |
Cadps |
Ca2+-dependent secretion activator |
149 |
0.97 |
chr4_73774316_73774478 | 5.65 |
Rasef |
RAS and EF hand domain containing |
16205 |
0.16 |
chr14_59737148_59737645 | 5.64 |
Gm19716 |
predicted gene, 19716 |
94848 |
0.07 |
chr12_29789878_29790063 | 5.62 |
Myt1l |
myelin transcription factor 1-like |
50240 |
0.17 |
chr18_57134558_57134765 | 5.61 |
Megf10 |
multiple EGF-like-domains 10 |
1571 |
0.38 |
chr19_14665137_14665294 | 5.61 |
Gm37997 |
predicted gene, 37997 |
6548 |
0.27 |
chr2_13470209_13470364 | 5.58 |
Cubn |
cubilin (intrinsic factor-cobalamin receptor) |
10806 |
0.25 |
chr7_73399870_73400476 | 5.57 |
Gm44758 |
predicted gene 44758 |
4177 |
0.15 |
chr12_3236518_3237725 | 5.56 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr2_79455687_79455958 | 5.55 |
Neurod1 |
neurogenic differentiation 1 |
929 |
0.42 |
chr10_75208297_75208464 | 5.51 |
Specc1l |
sperm antigen with calponin homology and coiled-coil domains 1-like |
3693 |
0.24 |
chr16_41551835_41552284 | 5.51 |
Lsamp |
limbic system-associated membrane protein |
18640 |
0.29 |
chr4_104269504_104269672 | 5.50 |
Dab1 |
disabled 1 |
97525 |
0.09 |
chr5_74999059_74999549 | 5.49 |
Gm42577 |
predicted gene 42577 |
10238 |
0.14 |
chr1_66388570_66388940 | 5.48 |
Map2 |
microtubule-associated protein 2 |
1744 |
0.39 |
chr11_113188158_113188571 | 5.44 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
13458 |
0.24 |
chr14_64589182_64589588 | 5.42 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
310 |
0.8 |
chr18_81509336_81509702 | 5.34 |
Gm50412 |
predicted gene, 50412 |
29162 |
0.19 |
chr6_16316868_16317055 | 5.30 |
Gm3148 |
predicted gene 3148 |
79334 |
0.1 |
chr13_97253425_97254036 | 5.26 |
Enc1 |
ectodermal-neural cortex 1 |
12625 |
0.16 |
chr16_42268964_42269115 | 5.24 |
Gap43 |
growth associated protein 43 |
7033 |
0.24 |
chr8_9772293_9772481 | 5.20 |
Fam155a |
family with sequence similarity 155, member A |
1226 |
0.34 |
chr12_104769312_104769526 | 5.20 |
Clmn |
calmin |
11452 |
0.2 |
chr3_80787222_80787380 | 5.19 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
15278 |
0.24 |
chr5_85239463_85240008 | 5.19 |
Gm21006 |
predicted gene, 21006 |
372890 |
0.01 |
chr2_181766649_181766810 | 5.16 |
Myt1 |
myelin transcription factor 1 |
300 |
0.87 |
chr12_49398215_49398490 | 5.15 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
7693 |
0.14 |
chr5_66675580_66675740 | 5.14 |
Uchl1os |
ubiquitin carboxy-terminal hydrolase L1, opposite strand |
373 |
0.51 |
chr10_25192682_25192961 | 5.13 |
Akap7 |
A kinase (PRKA) anchor protein 7 |
7337 |
0.22 |
chr13_84565715_84565948 | 5.12 |
Gm26913 |
predicted gene, 26913 |
125110 |
0.06 |
chr16_49194228_49194379 | 5.11 |
1700026J12Rik |
RIKEN cDNA 1700026J12 gene |
61469 |
0.13 |
chr3_122877642_122877947 | 5.11 |
Gm9364 |
predicted gene 9364 |
15881 |
0.12 |
chr1_13936038_13936249 | 5.10 |
Gm36947 |
predicted gene, 36947 |
87024 |
0.09 |
chr6_36858333_36858503 | 5.10 |
Ptn |
pleiotrophin |
48198 |
0.16 |
chr2_140861377_140861657 | 5.08 |
Calr-ps |
calreticulin, pseudogene |
94732 |
0.09 |
chr10_42340200_42340351 | 5.05 |
Gm15197 |
predicted gene 15197 |
9012 |
0.24 |
chr15_84531439_84531771 | 5.03 |
Rtl6 |
retrotransposon Gag like 6 |
26218 |
0.18 |
chr10_57783676_57784081 | 5.02 |
Fabp7 |
fatty acid binding protein 7, brain |
1003 |
0.44 |
chr4_16648254_16648590 | 5.01 |
Gm24978 |
predicted gene, 24978 |
27501 |
0.22 |
chr2_146057085_146057422 | 5.01 |
Cfap61 |
cilia and flagella associated protein 61 |
10002 |
0.26 |
chr13_84569455_84569857 | 5.01 |
Gm26913 |
predicted gene, 26913 |
121285 |
0.06 |
chr4_32432624_32432775 | 5.00 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
15264 |
0.25 |
chr3_62458622_62458788 | 4.99 |
Dhx36 |
DEAH (Asp-Glu-Ala-His) box polypeptide 36 |
13882 |
0.24 |
chr10_65125058_65125244 | 4.99 |
Gm28881 |
predicted gene 28881 |
4784 |
0.37 |
chr15_74162477_74162748 | 4.95 |
Gm15387 |
predicted gene 15387 |
68279 |
0.11 |
chr7_51928833_51929054 | 4.89 |
Gas2 |
growth arrest specific 2 |
2507 |
0.29 |
chr3_17797861_17798083 | 4.88 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
2228 |
0.25 |
chr18_33810064_33810215 | 4.86 |
Epb41l4a |
erythrocyte membrane protein band 4.1 like 4a |
7041 |
0.2 |
chr9_90693038_90693253 | 4.86 |
Gm2497 |
predicted gene 2497 |
40379 |
0.14 |
chr4_96273900_96274072 | 4.86 |
Cyp2j15-ps |
cytochrome P450, family 2, subfamily j, member 15, pseudogene |
284 |
0.91 |
chr6_94084728_94085068 | 4.85 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
171208 |
0.03 |
chr10_29856047_29856198 | 4.85 |
Gm6390 |
predicted gene 6390 |
74711 |
0.1 |
chr13_6131432_6131800 | 4.84 |
Gm47548 |
predicted gene, 47548 |
57834 |
0.13 |
chr6_137030356_137030507 | 4.81 |
Gm30055 |
predicted gene, 30055 |
43835 |
0.13 |
chr4_111686063_111686242 | 4.81 |
Spata6 |
spermatogenesis associated 6 |
33832 |
0.2 |
chr10_99353976_99354149 | 4.80 |
B530045E10Rik |
RIKEN cDNA B530045E10 gene |
48728 |
0.1 |
chr3_108510962_108511496 | 4.79 |
Gm23336 |
predicted gene, 23336 |
13111 |
0.08 |
chr1_55770047_55770346 | 4.76 |
Plcl1 |
phospholipase C-like 1 |
68171 |
0.13 |
chr5_71095239_71095609 | 4.74 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
224 |
0.97 |
chr8_26655862_26656270 | 4.74 |
Gm32098 |
predicted gene, 32098 |
12240 |
0.16 |
chr11_32158171_32158538 | 4.74 |
Gm12109 |
predicted gene 12109 |
26651 |
0.12 |
chr6_131294839_131294999 | 4.74 |
Magohb |
mago homolog B, exon junction complex core component |
1675 |
0.24 |
chr10_70952624_70952802 | 4.73 |
Bicc1 |
BicC family RNA binding protein 1 |
4224 |
0.2 |
chr1_67366568_67366878 | 4.73 |
Gm26342 |
predicted gene, 26342 |
109499 |
0.06 |
chr17_57799511_57799698 | 4.73 |
Cntnap5c |
contactin associated protein-like 5C |
30034 |
0.13 |
chr6_99042256_99042516 | 4.72 |
Foxp1 |
forkhead box P1 |
2056 |
0.41 |
chr3_118626776_118626987 | 4.67 |
Dpyd |
dihydropyrimidine dehydrogenase |
64695 |
0.11 |
chr13_97823915_97824432 | 4.67 |
Gm41031 |
predicted gene, 41031 |
1712 |
0.35 |
chr2_115460149_115460300 | 4.67 |
3110099E03Rik |
RIKEN cDNA 3110099E03 gene |
51977 |
0.15 |
chr12_51002047_51002408 | 4.67 |
Gm40421 |
predicted gene, 40421 |
2646 |
0.28 |
chr5_101830260_101830421 | 4.66 |
Gm20548 |
predicted gene 20548 |
7076 |
0.16 |
chr8_116053726_116053926 | 4.65 |
Gm45733 |
predicted gene 45733 |
81755 |
0.11 |
chr9_6250454_6250615 | 4.65 |
Ddi1 |
DNA-damage inducible 1 |
19312 |
0.26 |
chr10_87351386_87351607 | 4.64 |
Gm23191 |
predicted gene, 23191 |
12650 |
0.23 |
chr10_81230238_81230432 | 4.64 |
Atcay |
ataxia, cerebellar, Cayman type |
450 |
0.57 |
chr8_76072766_76072955 | 4.64 |
Gm45742 |
predicted gene 45742 |
44167 |
0.15 |
chr2_162413526_162413677 | 4.63 |
Ptprtos |
protein tyrosine phosphatase, receptor type T, opposite strand |
22788 |
0.27 |
chr18_9147444_9147969 | 4.63 |
Gm18526 |
predicted gene, 18526 |
47451 |
0.15 |
chr4_76155761_76156265 | 4.61 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
21870 |
0.28 |
chr17_3249667_3249818 | 4.60 |
Gm49797 |
predicted gene, 49797 |
18471 |
0.16 |
chr5_98842619_98842926 | 4.59 |
Bmp3 |
bone morphogenetic protein 3 |
11643 |
0.28 |
chr19_30826249_30826447 | 4.58 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
44896 |
0.2 |
chr7_46459937_46460151 | 4.56 |
Gm22969 |
predicted gene, 22969 |
9631 |
0.16 |
chr1_57218512_57218908 | 4.55 |
BC055402 |
cDNA sequence BC055402 |
3717 |
0.29 |
chr6_55388308_55389212 | 4.55 |
6430584L05Rik |
RIKEN cDNA 6430584L05 gene |
8127 |
0.17 |
chr17_69736615_69736970 | 4.55 |
Gm49895 |
predicted gene, 49895 |
39220 |
0.2 |
chr2_122221472_122221624 | 4.54 |
Rps12-ps10 |
ribosomal protein S12, pseudogene 10 |
1555 |
0.23 |
chr5_89727706_89728037 | 4.53 |
Gm25758 |
predicted gene, 25758 |
101000 |
0.08 |
chr18_74897508_74897936 | 4.50 |
Gm24559 |
predicted gene, 24559 |
8712 |
0.12 |
chr8_74921062_74921461 | 4.48 |
Isx |
intestine specific homeobox |
47721 |
0.13 |
chr17_59955724_59955911 | 4.48 |
Gm49853 |
predicted gene, 49853 |
100600 |
0.08 |
chr11_25704688_25704839 | 4.48 |
Gm23514 |
predicted gene, 23514 |
19623 |
0.26 |
chr7_88261931_88262082 | 4.48 |
Ctsc |
cathepsin C |
16079 |
0.22 |
chr18_31317015_31317210 | 4.48 |
Rit2 |
Ras-like without CAAX 2 |
1 |
0.98 |
chr4_117379821_117380196 | 4.48 |
Rnf220 |
ring finger protein 220 |
4551 |
0.2 |
chr6_25278174_25278333 | 4.47 |
Gm22529 |
predicted gene, 22529 |
78202 |
0.11 |
chr15_31989572_31989923 | 4.46 |
Gm49285 |
predicted gene, 49285 |
60204 |
0.14 |
chr14_13389203_13389354 | 4.43 |
Gm15913 |
predicted gene 15913 |
35198 |
0.18 |
chr13_96926120_96926484 | 4.43 |
Gcnt4 |
glucosaminyl (N-acetyl) transferase 4, core 2 (beta-1,6-N-acetylglucosaminyltransferase) |
1613 |
0.33 |
chr14_96392159_96392310 | 4.43 |
Gm24043 |
predicted gene, 24043 |
52721 |
0.16 |
chr4_23636183_23636497 | 4.43 |
Gm25978 |
predicted gene, 25978 |
9595 |
0.24 |
chr18_52403587_52403760 | 4.41 |
Srfbp1 |
serum response factor binding protein 1 |
62020 |
0.11 |
chr5_5283894_5284052 | 4.40 |
Cdk14 |
cyclin-dependent kinase 14 |
17670 |
0.17 |
chr1_190727415_190727906 | 4.40 |
Rps6kc1 |
ribosomal protein S6 kinase polypeptide 1 |
82803 |
0.09 |
chr1_89750576_89750818 | 4.39 |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
38466 |
0.16 |
chr15_58806245_58806504 | 4.38 |
Gm24041 |
predicted gene, 24041 |
13104 |
0.14 |
chr3_75085844_75086059 | 4.37 |
Zbbx |
zinc finger, B-box domain containing |
57752 |
0.14 |
chr17_90837137_90837297 | 4.36 |
4930480K15Rik |
RIKEN cDNA 4930480K15 gene |
23952 |
0.22 |
chr5_15846906_15847067 | 4.36 |
Gm42453 |
predicted gene 42453 |
23261 |
0.13 |
chr4_12263404_12263560 | 4.36 |
Gm11846 |
predicted gene 11846 |
7917 |
0.21 |
chr11_66694776_66694950 | 4.35 |
Gm12297 |
predicted gene 12297 |
131256 |
0.05 |
chr7_19175722_19176163 | 4.35 |
Eml2 |
echinoderm microtubule associated protein like 2 |
479 |
0.59 |
chr7_34570196_34571084 | 4.35 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr2_110189089_110189361 | 4.34 |
Gm13936 |
predicted gene 13936 |
7664 |
0.19 |
chr1_40764807_40765029 | 4.33 |
Gm37915 |
predicted gene, 37915 |
6467 |
0.17 |
chr6_75602367_75602546 | 4.33 |
4933439N06Rik |
RIKEN cDNA 4933439N06 gene |
28998 |
0.25 |
chr7_65049359_65049510 | 4.32 |
Gm25249 |
predicted gene, 25249 |
92858 |
0.07 |
chr8_22192503_22192656 | 4.31 |
Vps36 |
vacuolar protein sorting 36 |
230 |
0.89 |
chr7_37231070_37231224 | 4.31 |
Gm28077 |
predicted gene 28077 |
68118 |
0.1 |
chr14_17742379_17742530 | 4.30 |
Gm48320 |
predicted gene, 48320 |
28668 |
0.23 |
chr18_55190877_55191196 | 4.29 |
Gm22597 |
predicted gene, 22597 |
11196 |
0.23 |
chr14_59819467_59819618 | 4.29 |
Gm19716 |
predicted gene, 19716 |
176994 |
0.03 |
chr7_90886789_90887161 | 4.29 |
Gm45159 |
predicted gene 45159 |
97 |
0.92 |
chr5_84153090_84153587 | 4.28 |
Hmgn2-ps1 |
high mobility group nucleosomal binding domain 2, pseudogene 1 |
30025 |
0.25 |
chr11_41532495_41533004 | 4.28 |
Hspd1-ps3 |
heat shock protein 1 (chaperonin), pseudogene 3 |
34012 |
0.2 |
chr2_173266388_173266546 | 4.27 |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
9722 |
0.18 |
chr1_47164492_47164664 | 4.27 |
Gm28826 |
predicted gene 28826 |
11117 |
0.28 |
chr13_58896283_58896457 | 4.26 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
24635 |
0.18 |
chr12_51002470_51002650 | 4.24 |
Gm40421 |
predicted gene, 40421 |
2313 |
0.29 |
chr2_22029112_22029317 | 4.24 |
Gm13337 |
predicted gene 13337 |
38612 |
0.22 |
chr16_63806140_63806298 | 4.24 |
Epha3 |
Eph receptor A3 |
57194 |
0.14 |
chr16_77238960_77239248 | 4.24 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
2785 |
0.32 |
chr16_35591757_35592233 | 4.23 |
Gm5963 |
predicted pseudogene 5963 |
18439 |
0.18 |
chr15_99808455_99808616 | 4.22 |
Gm4468 |
predicted gene 4468 |
2047 |
0.15 |
chr7_112233365_112233549 | 4.22 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
7567 |
0.28 |
chr15_78686963_78687251 | 4.21 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
11881 |
0.14 |
chr3_3645756_3645933 | 4.21 |
Hnf4g |
hepatocyte nuclear factor 4, gamma |
11694 |
0.27 |
chr8_54792185_54792382 | 4.19 |
Wdr17 |
WD repeat domain 17 |
67779 |
0.1 |
chr13_90293866_90294059 | 4.19 |
Gm37054 |
predicted gene, 37054 |
55790 |
0.13 |
chr18_44520470_44520631 | 4.19 |
Mcc |
mutated in colorectal cancers |
1034 |
0.65 |
chr16_24509582_24509735 | 4.19 |
Morf4l1-ps1 |
mortality factor 4 like 1, pseudogene 1 |
19736 |
0.22 |
chr1_66495487_66495638 | 4.18 |
Unc80 |
unc-80, NALCN activator |
27115 |
0.18 |
chr1_10254179_10254614 | 4.18 |
Arfgef1 |
ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) |
21726 |
0.2 |
chr2_5566824_5566977 | 4.17 |
Gm13216 |
predicted gene 13216 |
36671 |
0.2 |
chr18_25678184_25678915 | 4.15 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chr5_111113715_111114064 | 4.15 |
Gm43677 |
predicted gene 43677 |
44422 |
0.13 |
chr14_75455687_75456060 | 4.15 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
109 |
0.97 |
chr13_49320451_49320839 | 4.15 |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
334 |
0.89 |
chr3_41102303_41102454 | 4.14 |
Pgrmc2 |
progesterone receptor membrane component 2 |
19332 |
0.18 |
chr14_79971535_79971686 | 4.14 |
Gm6999 |
predicted gene 6999 |
1360 |
0.42 |
chr4_65611314_65611465 | 4.14 |
Trim32 |
tripartite motif-containing 32 |
6140 |
0.35 |
chr10_49256654_49256820 | 4.14 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
13701 |
0.18 |
chr8_69160726_69160877 | 4.12 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
19848 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.2 | 6.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.1 | 6.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
2.0 | 8.2 | GO:0007412 | axon target recognition(GO:0007412) |
1.9 | 3.9 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.7 | 5.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.6 | 4.7 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.4 | 4.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.4 | 4.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.4 | 1.4 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.4 | 5.5 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.4 | 6.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.3 | 4.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.3 | 3.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.2 | 3.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.2 | 3.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.2 | 4.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.2 | 3.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.1 | 3.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.1 | 2.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.1 | 2.2 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.1 | 2.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.0 | 3.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.0 | 8.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
1.0 | 3.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.0 | 6.0 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.0 | 2.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.0 | 3.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.0 | 10.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.0 | 5.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.0 | 5.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 3.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.9 | 3.8 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.9 | 6.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.9 | 5.5 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.9 | 3.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.9 | 3.7 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.9 | 4.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.9 | 0.9 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.9 | 18.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.9 | 2.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.9 | 3.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.9 | 1.7 | GO:0060594 | mammary gland specification(GO:0060594) |
0.9 | 1.7 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.9 | 0.9 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.8 | 11.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.8 | 3.4 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.8 | 0.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.8 | 1.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.8 | 6.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.8 | 2.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.8 | 0.8 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.8 | 4.0 | GO:0046618 | drug export(GO:0046618) |
0.8 | 3.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.8 | 7.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.8 | 2.4 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.8 | 2.3 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.8 | 1.5 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.8 | 3.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.7 | 1.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.7 | 2.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.7 | 2.9 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 2.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 2.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 2.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.7 | 2.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.7 | 1.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.7 | 2.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.7 | 4.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.7 | 1.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.7 | 2.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.7 | 3.4 | GO:0031223 | auditory behavior(GO:0031223) |
0.7 | 2.0 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 1.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.6 | 1.3 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.6 | 1.9 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.6 | 1.3 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.6 | 7.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 5.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.6 | 1.9 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.6 | 1.8 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.6 | 3.0 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.6 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 11.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.6 | 2.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.6 | 4.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.6 | 3.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 3.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.6 | 1.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.6 | 2.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.6 | 2.2 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 1.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.6 | 0.6 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.5 | 0.5 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.5 | 1.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.5 | 1.1 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.5 | 2.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.5 | 2.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 1.6 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.5 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.5 | 3.6 | GO:0071625 | vocalization behavior(GO:0071625) |
0.5 | 1.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.5 | 2.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.5 | 2.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 1.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.5 | 1.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.5 | 2.5 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.5 | 0.5 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.5 | 4.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.5 | 0.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.5 | 1.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 1.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.5 | 1.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 2.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.5 | 1.9 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.5 | 1.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.5 | 0.9 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.5 | 2.3 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.5 | 1.4 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 2.8 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.5 | 1.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.5 | 9.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 0.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.5 | 2.3 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.5 | 0.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.4 | 1.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 2.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 0.9 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 0.4 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.4 | 0.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.4 | 1.3 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 0.9 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.4 | 0.9 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.4 | 1.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 1.7 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.4 | 0.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 1.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 0.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.4 | 0.4 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
0.4 | 0.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.4 | 7.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 0.4 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.4 | 2.9 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.4 | 1.2 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 4.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.4 | 1.2 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.4 | 1.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 1.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 1.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 2.0 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.4 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.4 | 1.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.4 | 0.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 1.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.4 | 0.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.4 | 2.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 0.8 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.4 | 2.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 2.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 1.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.4 | 0.4 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.4 | 5.2 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 2.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 3.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 1.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.4 | 1.5 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.4 | 1.8 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.4 | 1.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.4 | 1.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 2.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.4 | 0.7 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.4 | 1.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.4 | 0.4 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.4 | 1.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.4 | 1.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.4 | 1.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 0.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 2.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.3 | 1.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 1.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.7 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 3.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.7 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 0.7 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 1.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 1.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 1.0 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.3 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 1.0 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 1.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 1.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.3 | 1.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 1.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 3.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 0.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 1.0 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 0.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 1.0 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 0.3 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.3 | 1.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 1.3 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 0.6 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 1.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 0.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 1.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 0.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 0.6 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
0.3 | 1.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 2.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 1.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 0.3 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.3 | 3.9 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 1.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.3 | 0.6 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 1.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.3 | 1.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 0.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 0.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.3 | 0.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 0.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 5.2 | GO:0031111 | negative regulation of microtubule depolymerization(GO:0007026) negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.3 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 0.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 0.3 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.3 | 2.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 2.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.3 | 2.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 0.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.6 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 1.4 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.3 | 0.3 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.3 | 1.1 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.3 | 0.8 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 0.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 0.8 | GO:0035106 | operant conditioning(GO:0035106) |
0.3 | 20.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 1.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 0.3 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 11.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.8 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 0.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 0.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 1.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 2.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 3.5 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.2 | 1.2 | GO:0034776 | response to histamine(GO:0034776) |
0.2 | 0.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 1.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 1.4 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 0.7 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 1.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.5 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.2 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.2 | 1.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 1.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.7 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.9 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.2 | 0.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 1.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 5.0 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.2 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 1.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 1.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.2 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 1.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 1.5 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 2.1 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.2 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 1.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 0.6 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 0.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 4.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 1.6 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.8 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 0.6 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 1.0 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.6 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.2 | 1.4 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 1.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 1.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 0.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.4 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 1.7 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 0.8 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.2 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.2 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.2 | 0.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 1.1 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.2 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 0.6 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.2 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.7 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 1.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 1.4 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 1.8 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 1.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.9 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.3 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 1.7 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.2 | 0.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.2 | 0.8 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 1.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 0.5 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.2 | 0.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.7 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 0.8 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.2 | 1.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.6 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 1.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.6 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.2 | 1.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 2.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.5 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 1.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.6 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.6 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0072131 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.1 | 0.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 1.0 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 1.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.1 | 0.7 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.3 | GO:0060214 | endocardium formation(GO:0060214) |
0.1 | 0.5 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 1.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.7 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 0.4 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.4 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.4 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.5 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.0 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 1.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 2.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.5 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 1.7 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.6 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.1 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.4 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.5 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) |
0.1 | 0.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.2 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.1 | 1.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 1.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.1 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.7 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.4 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 2.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 1.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.3 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.1 | 2.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 2.1 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 1.0 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 0.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 2.2 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.1 | 0.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 5.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.1 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 1.0 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.9 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.2 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.1 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.2 | GO:0070472 | regulation of uterine smooth muscle contraction(GO:0070472) |
0.1 | 0.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.2 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 1.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.2 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.1 | 1.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.4 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.3 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 2.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.1 | 0.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.7 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.4 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.4 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.9 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 1.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 2.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.6 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.5 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.2 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.1 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.1 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:0032224 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 | 0.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.6 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.2 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.3 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.3 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 1.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.5 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.5 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.1 | GO:0043476 | pigment accumulation(GO:0043476) |
0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.4 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.1 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.2 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 1.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.1 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.3 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.2 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.1 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 1.5 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.0 | 0.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.0 | GO:0036166 | phenotypic switching(GO:0036166) |
0.0 | 1.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.4 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 2.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.3 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0003289 | endocardium development(GO:0003157) atrial septum primum morphogenesis(GO:0003289) |
0.0 | 0.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.0 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.8 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.6 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 2.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.0 | 0.0 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0086019 | cell-cell signaling involved in cardiac conduction(GO:0086019) |
0.0 | 0.0 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.0 | 0.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.0 | 0.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.4 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.2 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.1 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:1902661 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.0 | 0.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.1 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.4 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.0 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.0 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.0 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.0 | 0.0 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.0 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 6.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.2 | 3.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.1 | 3.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.1 | 7.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.0 | 1.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.9 | 2.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 8.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 4.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.8 | 3.3 | GO:1990357 | terminal web(GO:1990357) |
0.8 | 4.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 2.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 1.3 | GO:0000802 | transverse filament(GO:0000802) |
0.6 | 2.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.6 | 4.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 4.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 1.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 2.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.6 | 2.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.6 | 2.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 1.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.5 | 1.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 5.4 | GO:0060091 | kinocilium(GO:0060091) |
0.5 | 9.1 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 3.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.5 | 2.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 3.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 2.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 0.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 3.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 12.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 3.2 | GO:0000801 | central element(GO:0000801) |
0.4 | 5.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 1.8 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 11.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 1.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 0.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 2.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 0.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.4 | 14.8 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.4 | 0.8 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 3.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 0.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 5.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 15.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 1.4 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 1.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.5 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 0.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 1.4 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 0.6 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 3.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 0.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.3 | 1.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 2.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.5 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 1.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 1.1 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 1.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 7.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 3.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 2.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 1.8 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 1.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 0.8 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 1.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 1.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 1.1 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 1.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 9.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.8 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 3.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.5 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 7.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 4.6 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 1.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 5.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 12.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.4 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.2 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 1.0 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 1.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 1.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 1.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 1.0 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 1.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 1.7 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.1 | 10.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.0 | 6.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.9 | 5.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.8 | 5.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.5 | 4.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.4 | 5.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.2 | 3.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.1 | 1.1 | GO:0003896 | DNA primase activity(GO:0003896) |
1.1 | 6.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.1 | 4.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.1 | 3.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.1 | 4.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.0 | 5.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.0 | 2.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.9 | 2.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.8 | 3.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.8 | 6.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.8 | 3.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.7 | 2.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.7 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 9.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.7 | 10.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.7 | 2.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.7 | 0.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.7 | 2.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 1.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.6 | 3.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.6 | 4.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.6 | 1.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.6 | 15.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.6 | 3.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.6 | 2.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 4.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 2.8 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.6 | 1.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.5 | 2.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 1.6 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 1.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 2.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 1.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.5 | 3.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 6.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.5 | 1.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 2.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 2.6 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.4 | 1.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 1.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 2.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 1.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.4 | 1.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 4.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 1.6 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.4 | 2.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 0.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 3.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.4 | 0.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 1.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 4.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 5.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 1.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 1.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 2.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 3.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 0.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 2.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 1.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 1.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 2.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 2.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 1.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 0.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 2.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 0.9 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 0.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 0.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 0.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 1.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 1.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 5.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 5.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 1.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 1.4 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 2.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 0.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 0.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 1.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 0.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 0.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 1.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 3.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 1.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 2.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 1.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 1.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 1.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 1.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 3.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 1.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 5.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 2.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 1.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 1.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 1.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.6 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 1.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 5.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 1.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.6 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 2.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 2.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 2.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 2.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 1.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.8 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 1.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 1.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 2.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 2.4 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.2 | 0.4 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.2 | 2.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 2.0 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 1.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 3.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 1.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 3.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.1 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 0.5 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 4.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 2.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 4.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 3.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 1.0 | GO:0050542 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 2.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 5.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 3.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.5 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.1 | 0.3 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 1.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 1.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.5 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 3.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 2.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.5 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 4.1 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.5 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 1.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 2.4 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 2.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 1.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 1.5 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.3 | GO:0004787 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.4 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 0.0 | GO:0034874 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 0.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 0.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 4.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 10.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 2.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 5.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 4.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 2.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 3.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 1.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 4.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 6.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 11.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 4.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 2.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 2.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 2.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 12.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.9 | 10.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.9 | 0.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 8.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.7 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.7 | 6.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.7 | 6.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.5 | 10.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 9.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 14.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.4 | 2.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.4 | 0.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 10.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 0.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 7.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 6.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 2.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 5.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 3.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 4.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 3.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 1.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 1.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 3.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 2.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 2.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 3.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 0.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 1.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 3.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 2.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 2.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 1.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 3.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 1.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 2.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.6 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 1.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |